DEB catheter
ProcedureDEB catheter (trade name: Litos/Tulip)
NCT Number: NCT02137577
The purpose of this study is to determine whether DEB is more effective than common PTA balloon using under in long-term vessel patency and inhibiting restenosis in the infrapopliteal artery.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Peking Union Medical College Hospital, Beijing, China
PTA is an established alternative to open surgical bypass for the treatment of infrainginual disease of critical limb ischemia.
DEBs are designed to promote arterial patency by reducing neointimal proliferation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
DEB catheter (trade name: Litos/Tulip)
common PTA balloon catheter
Time frame: 6 months
Freedom from target vessel occlusion and clinically driven target lesion reintervention
Time frame: during the operation(after using the DEB catheter)
DEB catheter can reach the target lesions, expand as expected(not broken), and withdraw successfully.
Time frame: during the operation(after using the DEB catheter)
The blood supply of the target lesion recovered after treatment, and residual stenosis less than 50%
Time frame: during the operation(after using the DEB catheter)
both device succeed and technical succeed, and without clinical complication
Time frame: 6 months, 12 months,18 months, 24 months
Clinically driven TLR is defined as revascularization performed on a patient who returns with clinical symptoms such as: resting pain occur again, ulcer deterioration, new foot ulcers
Time frame: 6 months
measure difference of the MLD(minimal lumen diameter) at 0 time and 6 months
Time frame: 6 months, 12 months
Healed or not, if not, improving,stagnant, worsening
Time frame: 6 months, 12 months, 18 months, 24 months
Healed or not
Time frame: 6 months
measure ankle brachial index
>1.3 Vascular wall calcification is severe
0.9~1.1 Normal range
0.5~0.8 Mild and moderate ischemia of lower limb arteries
<0.5 severe ischemia
Time frame: 6 months, 12 months,18 months, 24 months
based the following definition of Rutherford stage, evaluate the stage of patient. Then compare the stage of patient just after procedure and 6 months after treatment
Stage clinical symptom
0 asymptomatic
Time frame: 30 days, 6 months, 12 months,18 months, 24 months
No Amputation of target limb
Acotec Scientific Co., Ltd
Industry
Prospective, Multi-center and Randomized Controlled Clinical Study to Verify Effectiveness and Safety of Drug-eluting Balloon in PTA Procedure of the Infrapopliteal Artery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT04377126
Arterial Occlusive Diseases, Arteriosclerosis
Chicago, Illinois, United States
View Trial DetailsNCT06890208
Anxiety Disorders, Arrhythmias, Cardiac
Hamburg, Germany
View Trial DetailsNCT05007925
Arterial Occlusive Diseases, Arteriosclerosis
Fresno, California, United States
View Trial Details